The differences in thrombolytic effects of administrated recombinant t-PA between Japanese and Caucasians.
Ueshima
Shigeru
S
Matsuo
Osamu
O
D044466:Asian People; D005343:Fibrinolytic Agents / Q000008:administration & dosage / Q000494:pharmacology*; D006801:Humans; D007700:Kinetics; D044469:Racial Groups; D011994:Recombinant Proteins / Q000008:administration & dosage / Q000494:pharmacology; D015912:Thrombolytic Therapy / Q000379:methods; D010959:Tissue Plasminogen Activator / Q000008:administration & dosage / Q000494:pharmacology*; D016896:Treatment Outcome; D014654:Vascular Patency / Q000187:drug effects; D044465:White People
D005343:Fibrinolytic Agents; D011994:Recombinant Proteins; D010959:Tissue Plasminogen Activator